Envirotech Vehicles, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Envirotech Vehicles, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $425.0K | Mar 12, 2018 |
| FY2017 | Dec 31, 2016 | $68.0K | Mar 12, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($13.20M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $488.8K | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $1.01M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $1.73M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $761.4K | Sep 25, 2023 |
| FY2021 | Dec 31, 2020 | $15.2K | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | $934.0K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $133.0K | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | ($54.0K) | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $18.0K | Mar 12, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($39.13M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($8.85M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | ($12.68M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($43.80M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($7.65M) | Sep 25, 2023 |
| FY2021 | Dec 31, 2020 | ($279.5K) | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | ($5.15M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($11.05M) | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | ($21.90M) | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | ($10.69M) | Mar 12, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($38.68M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($7.92M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | ($12.71M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($43.85M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($7.72M) | Sep 25, 2023 |
| FY2021 | Dec 31, 2020 | ($411.0K) | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | ($5.21M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($11.38M) | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | ($21.60M) | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | ($9.53M) | Mar 12, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $731.8K | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $192.9K | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $236.2K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $149.9K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $58.1K | Sep 25, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | $108.8K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $686.4K | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | $586.9K | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $37.3K | Mar 12, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.59M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($3.50M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | ($4.71M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($7.43M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($12.94M) | Sep 25, 2023 |
| FY2021 | Dec 31, 2020 | $1.53M | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | ($4.58M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($4.51M) | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | ($5.58M) | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | ($2.91M) | Mar 12, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $176.8K | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $430.3K | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $35.8K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $168.6K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $28.0K | Sep 25, 2023 |
| FY2021 | Dec 31, 2020 | $73.1K | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | $13.0K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $79.0K | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | $114.0K | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $411.0K | Mar 12, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.67M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $32.67M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $22.65M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $33.48M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $75.31M | Sep 25, 2023 |
| FY2021 | Dec 31, 2020 | $2.41M | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | $10.32M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $10.83M | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | $5.32M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $3.41M | Mar 12, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.60M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $11.75M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $2.02M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $1.49M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.57M | Sep 25, 2023 |
| FY2021 | Dec 31, 2020 | $2.88M | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | $7.04M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.23M | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | $2.98M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $6.11M | Mar 12, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($8.93M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $20.92M | Apr 13, 2026 |
| FY2025 | Dec 31, 2023 | $20.63M | Apr 13, 2026 |
| FY2024 | Dec 31, 2022 | $31.99M | Apr 15, 2025 |
| FY2023 | Dec 31, 2021 | $73.74M | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | ($472.2K) | Sep 25, 2023 |
| FY2021 | Dec 31, 2019 | ($192.7K) | Apr 26, 2022 |
| FY2020 | Dec 31, 2018 | $7.60M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $2.34M | Mar 10, 2020 |
| FY2018 | Dec 31, 2016 | ($2.71M) | Feb 19, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $10.10M | Apr 13, 2026 |
| FY2025 | Dec 31, 2023 | $9.58M | Apr 13, 2026 |
| FY2024 | Dec 31, 2022 | $14.68M | Apr 15, 2025 |
| FY2023 | Dec 31, 2021 | $51.78M | Mar 28, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($112.59M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($73.46M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | ($64.61M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($51.93M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($8.12M) | Sep 25, 2023 |
| FY2021 | Dec 31, 2020 | ($472.3K) | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | ($59.18M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($54.03M) | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | ($42.98M) | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | ($21.07M) | Mar 12, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $359.0K | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.94M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $456.7K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $2.77M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $4.85M | Sep 25, 2023 |
| FY2021 | Dec 31, 2020 | $136.2K | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | $4.43M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.76M | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | $2.45M | Feb 19, 2019 |
| FY2018 | Dec 31, 2016 | $938.0K | Feb 19, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $485.8K | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | $3.38M | Apr 15, 2025 |
| FY2023 | Dec 31, 2023 | $279.7K | Mar 28, 2024 |
| FY2017 | Dec 31, 2017 | $2.15M | Mar 12, 2018 |
| FY2017 | Dec 31, 2016 | $5.77M | Mar 12, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (11) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | (5) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | (2) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Sep 25, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.74M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | 1.99M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | 15.17M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 15.02M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 14.91M | Sep 25, 2023 |
| FY2022 | Mar 16, 2021 | 12.77M | Sep 25, 2023 |
| FY2021 | Dec 31, 2020 | 1 | Apr 26, 2022 |
| FY2020 | Dec 31, 2019 | 73.13M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 72.73M | Mar 10, 2020 |
| FY2018 | Dec 31, 2017 | 68.07M | Feb 19, 2019 |